Department of Pharmacology and Program in Neuroscience, University of Maryland School of Medicine, 655W. Baltimore St., Baltimore, MD, 21201, USA.
Neuropsychopharmacology. 2019 Jan;44(1):38-44. doi: 10.1038/s41386-018-0138-1. Epub 2018 Jun 29.
Identifying and understanding the sources of inherent risk to neurodevelopmental disorders is a fundamental goal of neuroscience. Being male or being exposed to inflammation early in life are two known risk factors, but they are only infrequently associated with each other. Cellular and molecular mechanisms mediating the masculinization of the brain in animal models reveal a consistent role for inflammatory signaling molecules and immune cells in the healthy male brain. Why this is so remains in the realm of speculation but may have its origins in the maternal immune system. Masculinization of the brain occurs during a restricted critical period that begins in utero and overlaps with the sensitive period during which maternal immune activation negatively impacts the developing brain. The convergence of maleness and early life inflammation as risk factors for neuropsychiatric disorders compels us to consider whether sexual differentiation of the brain in males creates an inherent and greater risk than that experienced by females.
确定和了解神经发育障碍的固有风险来源是神经科学的一个基本目标。男性或在生命早期暴露于炎症是两个已知的风险因素,但它们很少相互关联。动物模型中大脑雄性化的细胞和分子机制揭示了炎症信号分子和免疫细胞在健康男性大脑中的一致作用。为什么会这样仍然是推测,但可能起源于母体免疫系统。大脑的雄性化发生在一个受限的关键时期,从子宫内开始,并与母体免疫激活对发育中大脑产生负面影响的敏感时期重叠。男性和生命早期炎症作为神经精神疾病风险因素的趋同,迫使我们考虑男性大脑的性别分化是否比女性经历的风险更大。